Please provide your email address to receive an email when new articles are posted on . Metabolic surgery was associated with a 72% lower risk for incident major adverse liver outcomes vs. nonsurgical ...

Bariatric surgery significantly reduced long-term risk for decompensation and adverse outcomes in patients with obesity and compensated metabolic dysfunction-associated steatohepatitis (MASH)-related ...

Please provide your email address to receive an email when new articles are posted on . Metabolic surgery reduced major adverse liver outcomes in patients with MASH with compensated cirrhosis by 72%.

Among patients with obesity and compensated cirrhosis, bariatric surgery may significantly lower the risk of developing serious liver disease complications, according to a recent study by Cleveland ...

Data regarding risk factors and long-term outcomes of U.S. patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. This study aimed to investigate the ...

Originally linked to alcohol and caloric excess, fatty liver disease has evolved in classification. The redefinition of NAFLD to MASLD reflects its metabolic roots. MASH—marked by inflammation, ...

SGLT2 inhibitors were associated with significantly lower risks of kidney failure, cardiovascular events, mortality, and hepatic decompensation.